Ridgeback Capital Investments L.P. Quant / Systematic

Name: Ridgeback Capital Investments L.P. Q2 2026 13F Filing | 13F Explorer
Creator: Ridgeback Capital Investments L.P.
Published: 2026-08-14

Location: Miami Beach, FL

CIK: 0001423994 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $80.93M (100.0% shares, 0.0% debt)

Holdings (1)

New Positions (1)

REPL Replimune Group Inc. 100.0%

Value $80.93M Shares 7,310,656 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group Inc.	7,310,656	$80.93M	100.0%	—	—	COM	76029N106

Exited Positions (1)

PYXS Pyxis Oncology Inc 0.7%

Value $560K Shares 359,231 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PYXS	Pyxis Oncology Inc	359,231	$560K	0.7%	—	—	—	747324101